Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 686)
Posted On: 07/22/2020 2:27:02 PM
Post# of 154119
Posted By: blafarm
Re: MAV MD #44565
Quote:
I thought he said they have 100 patients in the CD-12 who have completed the trial (28 days+) and they would be taking an interim look at primary endpoints for this cohort

The DSMC investigation slated for next week is not an interim look.

It is a safety look only -- and we only have 100 who have completed the entire 28 duration of the trial.

The DSMC can decide to:

1. Terminate due to futility
2. Recommend proceeding to interim 50% (195)
3. Terminate due to overwhelming benefit

The interim look can only happen at 50% (195).

Last Saturday Dr.NP said there were 152 patients enrolled in the S/C.

Today, four days later, there are only 153 patients enrolled.

Therefore, we need 42 more enrolls.













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site